ECM Weekly (20th Feb 2022) - LIC, SBI Sumishin, Huitongda, Delhivery, Vedant, Persol, Emcure, Linom
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
493 Views
Linmon Media (柠萌影业) Pre-IPO - Consistently Putting up a Good Show
Linmon Media (LM HK) is looking to raise about US$300m in its upcoming Hong Kong IPO. In this note, we take a look at LM’s business, financials,...
539 Views
Lepu Biopharma (乐普生物科技) IPO: Sentiment Cooled Down
Downsized deal amid cooled sentiment for Chapter 18A, we think the valuation of Lepu Biopharm is not attractive for investors.
474 Views
Lepu Biopharma IPO: PHIP Updates
Lepu Biopharma (LBP HK) is a biopharmaceutical company focusing on oncology therapeutics. In this follow-up insight, we have highlighted new data...
557 Views
Lepu Biopharma IPO: No Monetisation Timeline in Sight
Lepu has a strong product portfolio with most of its products displaying a strong competitive advantage. However, the company is yet to generate...
601 Views